Ovarian carcinoma: Increase in clinical validity by simultaneous determination of SRA and CA 125


Ovarian carcinomas are distinguished by their polyclonality, i.e., heterogeneity and polymorphism of their tissue. There ist no marker available complying with the clinical demands in the case of ovarian carcinoma regarding statisfactory sensitivity and specificity. Therefore, we have simultaneously determined two entirely distinct tumor markers, serum… (More)
DOI: 10.1007/BF00390874


3 Figures and Tables